EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tristetraprolin attenuates schistosomiasis-induced liver fibrosis through m⁶A-mediated regulation of TGF-β1 mRNA stability

Xuejun Zhao, Xinyi Wang, Kejun Liu, Qian Fang, Cheng Wang, Guangbo Mei, Lihua Qu, Jiaxi Zhang, Jiayi Feng, Wenjuan Yang, Junnan Zhu, Hang Zhuo und 9 weitere

PLOS Pathogens · 13.05.2026 · 22 (5) · e1014007

DOI: 10.1371/journal.ppat.1014007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 13.05.2026. Verfasst von Xuejun Zhao und 20 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Province Key Laboratory of Allergy and Immunology, School of Basic Medical Sciences, Wuhan University, Wuhan, Hubei, People's Republic of China. Hauptthemen laut MEDLINE: Tristetraprolin, Liver Cirrhosis, RNA Stability, Transforming Growth Factor beta1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Foundation Project of Guizhou Health Commission, Natural Science Research Project of Guizhou Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inhibiting the activation of hepatic stellate cells (HSCs) represents a key therapeutic strategy for alleviating liver fibrosis induced by schistosomiasis. Diverse cell populations secrete pro-inflammatory cytokines and chemokines, which induce HSC activation and thereby promote hepatic fibrosis progression. Tristetraprolin (TTP) exerts a pivotal role in the post-transcriptional regulation of pro-inflammatory cytokines by either accelerating mRNA degradation or suppressing translation, a regulatory mechanism closely associated with the pathogenesis of various hepatic disorders. However, the pathological roles of TTP in Schistosoma japonicum -induced liver fibrosis remain largely elusive. Here, we report that TTP is upregulated in the liver during S. japonicum -induced liver fibrosis, and its overexpression markedly ameliorates this fibrotic pathology in vivo . We further identify that TTP negatively regulates TGF-β1 mRNA stability by promoting N6-methyladenosine (m 6 A) RNA methylation, thereby inhibiting HSC activation. Mechanistically, TTP enhances transcription of the WT1-associated protein ( WTAP ) gene through its interaction with SMAD2/3. Furthermore, treatment with an m 6 A RNA methylation inhibitor confirms that TTP-mediated protection against S. japonicum -induced liver fibrosis, an effect associated with increased m⁶A RNA methylation in vivo . Thus, our findings uncover a novel and critical role of TTP in exerting its anti-fibrotic function via the WTAP/m 6 A epitranscriptomic machinery in the pathogenesis of S. japonicum -induced liver fibrosis. This finding provides a rationale for the therapeutic targeting of TTP-mediated m 6 A RNA methylation in S. japonicum -induced liver fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TristetraprolinLiver CirrhosisRNA StabilityTransforming Growth Factor beta1Schistosomiasis japonicaAnimalsMiceHepatic Stellate CellsSchistosoma japonicumRNA MethylationRNA, MessengerMaleAdenosineMice, Inbred C57BL

Substanzen

TristetraprolinTransforming Growth Factor beta1Zfp36 protein, mouseRNA, MessengerAdenosine

Autor:innen und Institutionen

  • Hubei Province Key Laboratory of Allergy and Immunology, School of Basic Medical Sciences, Wuhan University, Wuhan, Hubei, People's Republic of China.
  • Department of Medical Parasitology, School of Basic Medical Sciences, Wuhan University, Wuhan, Hubei, People's Republic of China.
  • Department of Clinical Laboratory, Guizhou Provincial People's Hospital, Guiyang, Guizhou, People's Republic of China.
  • School of Basic Medical Sciences, Hubei University of Science and Technology, Xianning, Hubei, People's Republic of China.
  • Ecological Station of Oncomelania Hupensis in Gong'an County, Jingzhou, Hubei, People's Republic of China.
  • Wuhan Kindstar Diagnostics Co Ltd, Wuhan, Hubei, People's Republic of China.

ORCID-Profile: Rui Zhou

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Foundation Project of Guizhou Health Commission
  • Natural Science Research Project of Guizhou Province
  • Natural Science Foundation of Hubei Province

Zitieren

APA

Zhao, X., Wang, X., Liu, K., Fang, Q., Wang, C., Mei, G., Qu, L., Zhang, J., Feng, J., Yang, W., Zhu, J., Zhuo, H., Kuang, N., Qiu, X., Deng, Z., Luo, Q., Jin, X., Jiang, L., Li, X., …, & Zhou, R. (2026). Tristetraprolin attenuates schistosomiasis-induced liver fibrosis through m⁶A-mediated regulation of TGF-β1 mRNA stability. PLOS Pathogens, 22(5), e1014007. https://doi.org/10.1371/journal.ppat.1014007

Vancouver

Zhao X, Wang X, Liu K, Fang Q, Wang C, Mei G, et al. Tristetraprolin attenuates schistosomiasis-induced liver fibrosis through m⁶A-mediated regulation of TGF-β1 mRNA stability. PLOS Pathogens. 2026;22(5):e1014007. doi:10.1371/journal.ppat.1014007

BibTeX
@article{Zhao2026,
  author = {Zhao, Xuejun and Wang, Xinyi and Liu, Kejun and Fang, Qian and Wang, Cheng and Mei, Guangbo and Qu, Lihua and Zhang, Jiaxi and Feng, Jiayi and Yang, Wenjuan and Zhu, Junnan and Zhuo, Hang and Kuang, Na and Qiu, Xuebing and Deng, Zhigao and Luo, Qiong and Jin, Xiaoxia and Jiang, Lanxuan and Li, Xiaoqing and Dong, Huifen and Zhou, Rui},
  title = {Tristetraprolin attenuates schistosomiasis-induced liver fibrosis through m⁶A-mediated regulation of TGF-β1 mRNA stability},
  journal = {PLOS Pathogens},
  year = {2026},
  volume = {22},
  number = {5},
  pages = {e1014007},
  doi = {10.1371/journal.ppat.1014007}
}
Kostenlos starten →